Skip to main content
. 2018 Apr 24;15(4):400–410. doi: 10.1177/1479972318766140

Table 1.

Baseline characteristics of participants in the treatment and control groups.

Categorical variable Body scan (N = 40), n (%) Control (N = 40), n (%)
Female 20 (50.0) 19 (47.5)
Professional/managerial 10 (25.0) 11 (27.5)
Retired/cannot work 37 (92.5) 35 (87.5)
Caucasian 38 (95.0) 38 (95.0)
Married/living with partner 21 (52.5) 18 (45.0)
Medication used for symptomatic relief/prevention of COPD 40 (100) 40 (100)
Domiciliary oxygen therapy used 12 (30.0) 9 (22.5)
Use of recreational drugs 4 (10.0) 2 (5.0)
Smokers 10 (25.0) 11 (27.5)
Nicotine replacement therapy used 0 (0.0) 5 (12.5)
HADS anxiety
 Borderline (scores 8–10) 6 (15.0) 8 (20.0)
 Moderate to severe (scores 11–24) 10 (25.0) 10 (25.0)
HADS depression
 Borderline (scores 8–10) 10 (25.0) 8 (20.0)
 Moderate to severe (scores 11–24) 6 (15.0) 7 (17.5)
Continuous variables Mean (SD) Mean (SD)
Age 70.0 (10.3) 72.6 (9.8)
Years of full-time education 11.1 (2.4) 11.0 (2.6)
The BORG dyspnoea scale (0 to 10) 4.4 (2.7) 3.8 (2.3)
Abbreviated mental state score (scores 0–10) 9.8 (0.5) 9.7 (0.6)
Number of cigarettes per day (current smokers only) 17.0 (19.1) 14.2 (5.8)
HADS anxiety score (0–21) 7.3 (4.7) 7.7 (4.3)
HADS depression score (0–21) 6.5 (3.3) 7.0 (3.2)
PHLMS awareness score (10–50) 36.7 (6.0) 37.8 (5.4)
PHLMS acceptance score (10–50) 30.2 (7.4) 30.1 (7.3)

COPD: chronic obstructive pulmonary disease; HADS: Hospital Anxiety and Depression Scale; PHLMS: Philadelphia Mindfulness Scale; SD: standard deviation.